GB1152645A - Rubella Vaccine - Google Patents

Rubella Vaccine

Info

Publication number
GB1152645A
GB1152645A GB32603/67A GB3260367A GB1152645A GB 1152645 A GB1152645 A GB 1152645A GB 32603/67 A GB32603/67 A GB 32603/67A GB 3260367 A GB3260367 A GB 3260367A GB 1152645 A GB1152645 A GB 1152645A
Authority
GB
United Kingdom
Prior art keywords
culture
virus
rubella
rubella vaccine
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32603/67A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1152645A publication Critical patent/GB1152645A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1,152,645. Rubella vaccine. MERCK & CO. Inc. 14 July, 1967 [22 May, 1967], No. 32603/67. Heading A5B. A rubella vaccine is prepared by isolating rubella virus from clinical material by inoculation of chick embryo or grivet monkey tissue culture and incubating at 30-38‹C.; successively passing the virus through culture media to attenuate the virus at least one of such passages being in media comprising minced and trypsinised 9-11 day old decapitated and amputated chick embryo culture in a cell growth medium at 30-38‹C., each passage being followed by infectivity titrations on sample harvests taken at 2-14 day intervals, the harvests being frozen until tested and re-inoculated in a culture medium if too virulent. The serial passages may include incubations in grivet monkey kidney cultures, embryonated hen's eggs or duck embryo tissue cultures.
GB32603/67A 1967-05-22 1967-07-14 Rubella Vaccine Expired GB1152645A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64034167A 1967-05-22 1967-05-22

Publications (1)

Publication Number Publication Date
GB1152645A true GB1152645A (en) 1969-05-21

Family

ID=24567850

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32603/67A Expired GB1152645A (en) 1967-05-22 1967-07-14 Rubella Vaccine

Country Status (7)

Country Link
BE (1) BE701496A (en)
ES (1) ES343144A1 (en)
FI (1) FI43624B (en)
FR (1) FR1583642A (en)
GB (1) GB1152645A (en)
GR (1) GR33984B (en)
SE (1) SE318975B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2532548B1 (en) * 1982-09-03 1985-11-08 Pasteur Institut NOVEL PROCESS FOR THE PRODUCTION OF VACCINES HAVING A HIGH TITLE OF VIRUSES AND HIGHLY PURIFIED VACCINES, A HIGH TITLE OF VIRUSES, SO OBTAINED

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Also Published As

Publication number Publication date
FR1583642A (en) 1969-11-21
SE318975B (en) 1969-12-22
GR33984B (en) 1968-02-29
ES343144A1 (en) 1968-10-01
FI43624B (en) 1971-02-01
BE701496A (en) 1968-01-18

Similar Documents

Publication Publication Date Title
Robbins et al. Cytopathogenic Effect of Poliomyelitis Viruses In vitro on Human Embryonic Tissues.
Vogel et al. Adsorption-hemagglutination test for influenza virus in monkey kidney tissue culture
Hedrick et al. Two cell lines from white sturgeon
Kaaden et al. Establishment and characterization of chicken embryo fibroblast clone LSCC-H32
Ishizaki et al. Heterogeneity of strain R avian (erythroblastosis) virus
Burnstein et al. Persistent infection of BSC-1 cells by defective measles virus derived from subacute sclerosing panencephalitis
Davies et al. Characteristics of a Kenyan camelpox virus
CA1122527A (en) Influenza vaccine production in liquid cell culture
Smith et al. Growth of neurotropic viruses in extraneural tissues IV. Poliomyelitis virus in human testicular tissue in vitro.
Hahn et al. Lymphoproliferative diseases of fowl: JM-V leukemic lymphoblasts in cell culture: brief communication
Higbie et al. The behavior of the virus of equine encephalomyelitis on the chorioallantoic membrane of the developing chick
ES373631A1 (en) Live attenuated marek{40 s disease virus vaccine for poultry
Brandly Some Studies of Infectious Laryngotracheitis: The Continued Propagation of the Virus upon the Chorioallantoic Membrane of the Hen's Egg
Mackay Tissue culture studies of sheep pulmonary adenomatosis (jaagsiekte): II. Transmission of cytopathic effects to normal cultures
GB1152645A (en) Rubella Vaccine
Hihara et al. Conditions for successful cultivation of tumor cells from chickens with avian lymphoid leukosis
US3555149A (en) Mumps vaccine and its preparation
GB1152626A (en) Rubella Vaccine
Musser et al. Measles virus growth in canine renal cell cultures
Cutchins et al. Comparative susceptibility of cell cultures to vaccinia virus: application to the standardization of smallpox vaccine
Williamson et al. Factors influencing the production of developmental defects in the chick embryo following infection with Newcastle disease virus
JPH0998778A (en) Marek's disease vaccine
Wood et al. Cultivation of Poliomyelitis Virus in Tissue Culture III. Synthetic Medium in Roller Tube Cultures.
Eddy et al. Persistent infection of human carcinoma and primary chick embryo cell cultures with simian virus 40
Yoshino Infection of one-day-old fertile hen's egg with herpes simplex virus

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees